Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir. - Wikidata - wikimedia - TriplyDB

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

http://www.wikidata.org/entity/Q34310482

about

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

http://www.wikidata.org/entity/Q34310482

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@ast

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@en

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@nl

type

label

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@ast

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@en

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@nl

prefLabel

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@ast

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@en

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@nl

P1433

Q34310482-13CB9DBC-1C8D-4211-94E1-9B9BC0873DF6

P1476

Q34310482-34644917-BCE4-43D3-9A55-ECBFCE472818

P2093

Q34310482-0B83AFF5-E3FE-4E27-812B-DEC08632D3AC

Q34310482-0D8A8014-996D-4871-9675-0E06E5B81C61

Q34310482-145F6ADB-E0D6-4669-9AB3-25DDB604AFE8

Q34310482-1B403922-6AAD-4B19-89E2-F00FDE312A4B

Q34310482-206788E2-1411-4E82-8117-74ED78A5AB24

Q34310482-22DC25C3-A6B0-458C-907F-6AAF60A327DF

Q34310482-23B26CF3-4AD9-4A82-87A8-2C1F1CE29FC3

Q34310482-24BE69FE-5977-4D66-A1C6-3779BA19F334

Q34310482-26849B72-E4A7-4AB9-8D63-18F551CF80D6

Q34310482-326CAF75-E35C-49DE-924F-B5872B518C5C

P2860

Q34310482-02846420-B2AD-4712-91A3-05F8EC8CF42A

Q34310482-0730A605-326C-4216-95E4-349BD5F75A30

Q34310482-0AB9B6D0-B245-459D-A6EE-D8C1D785D246

Q34310482-1C14B7C5-D73D-4F7B-A7B7-1FA8BD730DB3

Q34310482-24625965-8705-4E45-A36A-FFA665676B4A

Q34310482-2474A55C-8ACD-4EF3-A659-47E5DCCF0E65

Q34310482-4CDA80EF-E65C-4FF7-AE68-765B56041C32

Q34310482-6B9E4456-FD1E-4159-BA9B-F1F16A8B324C

Q34310482-728211C1-3BA6-4D6F-9E35-1E13F186CB94

Q34310482-7836E796-E2F4-46F3-9348-F17840723FDE

P304

Q34310482-11C6373F-3DBB-4B2E-BBE9-2FCFF1914CB5

P31

Q34310482-1B18DDBE-CA28-4CFD-A964-E13CB312C1CA

P356

Q34310482-AF8BDD30-0875-45B6-81EC-EADF8BC26A64

P478

Q34310482-7AF3575D-E859-49DC-B5FB-E9D16FE1A154

P50

Q34310482-15089AAF-0BE8-47CD-991B-B920188DF504

Q34310482-AC352052-965B-4762-B7CF-620EFD707779

P577

Q34310482-32C55297-0D49-4811-9A34-DD6050AAAFD6

P5875

Q34310482-F7E33781-6A9E-4860-A1E4-2183062816EE

P698

Q34310482-A3E4B798-CDCF-4694-924F-DA2DE0E92C65

P932

Q34310482-16C7E53C-CD2A-4C4C-89E0-B73C29AAF818

P356

P1433

Infectious Diseases in Obstetrics and Gynecology

P1476

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

@en

P2093

Annemiek de Ruiter

http://www.w3.org/2001/XMLSchema#string

Charlotte Eve Short

http://www.w3.org/2001/XMLSchema#string

Claire Naftalin

http://www.w3.org/2001/XMLSchema#string

David Hawkins

http://www.w3.org/2001/XMLSchema#string

Gary Brook

http://www.w3.org/2001/XMLSchema#string

Graham Taylor

http://www.w3.org/2001/XMLSchema#string

Heather Noble

http://www.w3.org/2001/XMLSchema#string

Judith Zhou

http://www.w3.org/2001/XMLSchema#string

Katherine Smith

http://www.w3.org/2001/XMLSchema#string

Laura Byrne

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

Antiretroviral regimens in pregnancy and breast-feeding in Botswana.

Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.

Atazanavir pharmacokinetics with and without tenofovir during pregnancy

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy

Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009

Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.

P304

961375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/961375

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Bradshaw

P577

2014-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267101737

http://www.w3.org/2001/XMLSchema#string

P698

25328370

http://www.w3.org/2001/XMLSchema#string

P932

4190692

http://www.w3.org/2001/XMLSchema#string